These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19901984)

  • 1. Potent inhibition of HIV-1 replication by a Tat mutant.
    Meredith LW; Sivakumaran H; Major L; Suhrbier A; Harrich D
    PLoS One; 2009 Nov; 4(11):e7769. PubMed ID: 19901984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
    Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
    Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.
    Apolloni A; Lin MH; Sivakumaran H; Li D; Kershaw MH; Harrich D
    Hum Gene Ther; 2013 Mar; 24(3):270-82. PubMed ID: 23298160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes.
    Rustanti L; Jin H; Lor M; Lin MH; Rawle DJ; Harrich D
    Virol J; 2017 Mar; 14(1):52. PubMed ID: 28288662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex.
    Lin MH; Apolloni A; Cutillas V; Sivakumaran H; Martin S; Li D; Wei T; Wang R; Jin H; Spann K; Harrich D
    J Virol; 2015 May; 89(9):4827-36. PubMed ID: 25673710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong
    Jin H; Sun Y; Li D; Lin MH; Lor M; Rustanti L; Harrich D
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Effects of Strategies to Improve the Transduction Efficiency of Lentiviral Vector that Conveys an Anti-HIV Protein, Nullbasic, in Human T Cells.
    Rustanti L; Jin H; Li D; Lor M; Sivakumaran H; Harrich D
    Virol Sin; 2018 Apr; 33(2):142-152. PubMed ID: 29541943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.
    Echetebu CO; Rhim H; Herrmann CH; Rice AP
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):655-64. PubMed ID: 8207644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins.
    Fraisier C; Abraham DA; van Oijen M; Cunliffe V; Irvine A; Craig R; Dzierzak EA
    Gene Ther; 1998 Jul; 5(7):946-54. PubMed ID: 9813666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking.
    Lin MH; Sivakumaran H; Apolloni A; Wei T; Jans DA; Harrich D
    PLoS One; 2012; 7(12):e51466. PubMed ID: 23251541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis.
    Paik SY; Banerjea A; Chen CJ; Ye Z; Harmison GG; Schubert M
    Hum Gene Ther; 1997 Jun; 8(9):1115-24. PubMed ID: 9189769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.
    Kameoka M; Rong L; Götte M; Liang C; Russell RS; Wainberg MA
    J Virol; 2001 Mar; 75(6):2675-83. PubMed ID: 11222691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
    Ulich C; Harrich D; Estes P; Gaynor RB
    J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1.
    Neuveut C; Scoggins RM; Camerini D; Markham RB; Jeang KT
    J Biomed Sci; 2003; 10(6 Pt 1):651-60. PubMed ID: 14576468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat is required for efficient HIV-1 reverse transcription.
    Harrich D; Ulich C; García-Martínez LF; Gaynor RB
    EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.